Home/Filings/4/0001179110-13-017173
4//SEC Filing

MEDICINES CO /DE 4

Accession 0001179110-13-017173

CIK 0001113481operating

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 3:37 PM ET

Size

8.6 KB

Accession

0001179110-13-017173

Insider Transaction Report

Form 4
Period: 2013-11-25
Transactions
  • Sale

    Common Stock

    2013-11-25$37.19/sh17,039$633,68022,349 total
  • Exercise/Conversion

    Option (Right-to-buy)

    2013-11-2517,0390 total
    Exercise: $21.14Exp: 2023-05-22Common Stock (17,039 underlying)
  • Exercise/Conversion

    Common Stock

    2013-11-25$21.14/sh+17,039$360,20439,388 total
Footnotes (3)
  • [F1]The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Shigeta on October 25, 2013.
  • [F2]The range of prices for the transactions reported on this line is between $36.59 and $37.72 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.
  • [F3]As of November 25, 2013, the original grant (17,039 shares granted on May 22, 2012) was fully vested and exercised.

Issuer

MEDICINES CO /DE

CIK 0001113481

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001113481

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 3:37 PM ET
Size
8.6 KB